MEA Pemphigus Vulgaris Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	173 Pages	Data Bridge Market Research	June, 2023	DAABD18055232

Best Price Guarantee
Price	from $3,500
Length	173 Pages
Publisher	Data Bridge Market Research
Published Date	June, 2023
SKU	DAABD18055232

MEA Pemphigus Vulgaris Market - Industry Trends and Forecast to 2030

The Middle East and Africa pemphigus vulgaris market is expected to reach USD 31.17 million by 2030 from USD 18.53 million in 2022, growing at a CAGR of 6.8% during the forecast period of 2023 to 2030.

Market Segmentation:
Middle East and Africa Pemphigus Vulgaris Market, By Diagnosis and Treatment (Diagnosis, Treatment), Population Type (Pediatric, Adults, and Geriatric), End User (Hospitals, Specialty Clinics, Research Institutes, and Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy) - Industry Trends and Forecast to 2030

Overview of Middle East and Africa Pemphigus Vulgaris Market Dynamics:

Driver

• Rise in patients with rare diseases such as pemphigus vulgaris

Restraint

• High cost of treatment

Opportunity

• Rising healthcare facilities in the developing and underdeveloped countries

Market Players
The key market players operating in the market are:

• Novartis AG
• Amgen Inc.
• Merck & Co., Inc.
• AstraZeneca
• Teva Pharmaceutical Industries Ltd
• Lilly
• Zydus Group
• GSK plc.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Market Application Coverage Grid; 2.8 Product Lifeline Curve; 2.9 Dbmr Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter Five Forces; 4.3 Patent Analysis; 4.4 Patient Flow Diagram; 4.5 Key Pricing Strategies; 4.6 Future Therapies; 4.7 Key Patient Enrollment Strategies
5 Pipeline Analysis
6 Epidemiology
7 Industry Insights
8 Middle East & Africa Pemphigus Vulgaris Market: Regulations
9 Market Overview: 9.1 Drivers; 9.1.1 Emerging Treatment Options For Pemphigus Vulgaris; 9.1.2 Growing Support Of Ngos For The Affected Patients; 9.1.3 Awareness Regarding The Disease; 9.2 Restraints; 9.2.1 Strict Regulatory Guidelines; 9.2.2 High Treatment Costs; 9.3 Opportunities; 9.3.1 Increasing Demand For Personalized Medicine; 9.3.2 Increasing Healthcare Facilities; 9.3.3 Digital Health Technologies For Treatment Management; 9.4 Challenges; 9.4.1 Adverse Effects Associated With Medications; 9.4.2 Reimbursement And Coverage Policies
10 Middle East & Africa Pemphigus Vulgaris Market, By Diagnosis And Treatment: 10.1 Overview; 10.2 Treatment; 10.2.1 Medications, By Type; 10.2.1.1 Corticosteroids; 10.2.1.2 Steroid- Sparing Immunosuppressant Drugs; 10.2.1.2.1 Azathioprine; 10.2.1.2.2 Mycophenalate Mofetil; 10.2.1.2.3 Methotrexate; 10.2.1.2.4 Cyclophosphamide; 10.2.1.2.5 Mizoribine; 10.2.1.2.6 Others; 10.2.1.3 Anti- Inflammatory Agents; 10.2.1.3.1 Diaminodyphenyl Sulfone; 10.2.1.3.2 Tetracycline; 10.2.1.3.3 Others; 10.2.1.4 Biologics; 10.2.1.5 Intravenous Immunoglobulin; 10.2.1.6 Antibiotics; 10.2.1.7 Antifungals; 10.2.1.8 Antivirals; 10.2.1.9 Other Medications; 10.2.2 Medications, By Route Of Administration; 10.2.2.1 Oral; 10.2.2.2 Topical; 10.2.2.3 Parenteral; 10.2.2.4 Others; 10.2.3 Medications, By Drug Type; 10.2.3.1 Generic; 10.2.3.2 Branded; 10.3 Diagnosis; 10.3.1 Skin Biopsy; 10.3.2 Blood Test; 10.3.3 Endoscopy
11 Middle East & Africa Pemphigus Vulgaris Market, By Population Type: 11.1 Overview; 11.2 Adults; 11.3 Geriatric; 11.4 Pediatric
12 Middle East & Africa Pemphigus Vulgaris Market, By End User: 12.1 Overview; 12.2 Hospitals; 12.3 Specialty Clinics; 12.4 Research Institutes; 12.5 Others
13 Middle East & Africa Pemphigus Vulgaris Market, By Distribution Channel: 13.1 Overview; 13.2 Hospitals Pharmacy; 13.3 Retail Pharmacy; 13.4 Online Pharmacy
14 Middle East & Africa Pemphigus Vulgaris Market, By Region: 14.1 Middle East And Africa; 14.1.1 Saudi Arabia; 14.1.2 Egypt; 14.1.3 U.A.E.; 14.1.4 South Africa; 14.1.5 Israel; 14.1.6 Rest Of Middle East And Africa
15 Middle East & Africa Pemphigus Vulgaris Market, Company Landscape: 15.1 Company Share Analysis: Middle East & Africa
16 Swot Analysis
17 Company Profile: 17.1 Abbvie Inc.; 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Developments; 17.2 Merck & Co., Inc.,; 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Company Share Analysis; 17.2.4 Product Portfolio; 17.2.5 Recent Development; 17.3 Sanofi; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio; 17.3.5 Recent Development; 17.4 Regeneron Pharmaceuticals Inc.; 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Company Share Analysis; 17.4.4 Product Portfolio; 17.4.5 Recent Development; 17.5 Novartis Ag; 17.5.1 Company Snapshot; 17.5.2 Revenue Analysis; 17.5.3 Company Share Analysis; 17.5.4 Product Portfolio; 17.5.5 Recent Development; 17.6 Amgen Inc.; 17.6.1 Company Snapshot; 17.6.2 Revenue Analysis; 17.6.3 Product Portfolio; 17.6.4 Recent Developments; 17.7 Astrazeneca; 17.7.1 Company Snapshot; 17.7.2 Revenue Analysis; 17.7.3 Company Share Analysis; 17.7.4 Product Portfolio; 17.7.5 Recent Developments; 17.8 Boehringer Ingelheim International Gmbh; 17.8.1 Company Snapshot; 17.8.2 Revenue Analysis; 17.8.3 Product Portfolio; 17.8.4 Recent Development; 17.9 Celltrion Healthcare Co., Ltd; 17.9.1 Company Snapshot; 17.9.2 Revenue Analysis; 17.9.3 Product Portfolio; 17.9.4 Recent Developments; 17.10 F. Hoffmann- La Roche Ltd.; 17.10.1 Company Snapshot; 17.10.2 Revenue Analysis; 17.10.3 Product Portfolio; 17.10.4 Recent Development; 17.11 Fresenius Kabi Ag; 17.11.1 Company Snapshot; 17.11.2 Revenue Analysis; 17.11.3 Product Portfolio; 17.11.4 Recent Development; 17.12 Gsk Plc; 17.12.1 Company Snapshot; 17.12.2 Revenue Analysis; 17.12.3 Product Portfolio; 17.12.4 Recent Development; 17.13 Johnson & Johnson Services, Inc.; 17.13.1 Company Snapshot; 17.13.2 Revenue Analysis; 17.13.3 Company Share Analysis; 17.13.4 Product Portfolio; 17.13.5 Recent Development; 17.14 Lilly; 17.14.1 Company Snapshot; 17.14.2 Revenue Analysis; 17.14.3 Product Portfolio; 17.14.4 Recent Development; 17.15 Pfizer Inc.; 17.15.1 Company Snapshot; 17.15.2 Revenue Analysis; 17.15.3 Product Portfolio; 17.15.4 Recent Development; 17.16 Rakshit Drugs Pvt. Ltd; 17.16.1 Company Snapshot; 17.16.2 Product Portfolio; 17.16.3 Recent Development; 17.17 Teva Pharmaceutical Industries Ltd; 17.17.1 Company Snapshot; 17.17.2 Revenue Analysis; 17.17.3 Product Portfolio; 17.17.4 Recent Development; 17.18 Zydus Group; 17.18.1 Company Snapshot; 17.18.2 Revenue Analysis; 17.18.3 Product Portfolio; 17.18.4 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 Middle East & Africa Pemphigus Vulgaris Market, Patent Analysis; Table 2 Middle East & Africa Pemphigus Vulgaris Market, Pipeline Analysis; Table 3 Middle East & Africa Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million); Table 4 Middle East & Africa Treatment In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 5 Middle East & Africa Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 6 Middle East & Africa Steroid- Sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 7 Middle East & Africa Anti- Inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 8 Middle East & Africa Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million); Table 9 Middle East & Africa Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million); Table 10 Middle East & Africa Diagnosis In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 11 Middle East & Africa Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 12 Middle East & Africa Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million); Table 13 Middle East & Africa Adults In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 14 Middle East & Africa Geriatric In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 15 Middle East & Africa Pediatric In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 16 Middle East & Africa Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million); Table 17 Middle East & Africa Hospitals In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 18 Middle East & Africa Specialty Clinics In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 19 Middle East & Africa Research Institutes In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 20 Middle East & Africa Others In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 21 Middle East & Africa Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million); Table 22 Middle East & Africa Hospitals Pharmacy In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 23 Middle East & Africa Retail Pharmacy In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 24 Middle East & Africa Online Pharmacy In Pemphigus Vulgaris Market, By Region, 2021-2030 (Usd Million); Table 25 Middle East And Africa Pemphigus Vulgaris Market, By Country, 2021-2030 (Usd Million); Table 26 Middle East And Africa Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million); Table 27 Middle East And Africa Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 28 Middle East And Africa Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 29 Middle East And Africa Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 30 Middle East And Africa Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million); Table 31 Middle East And Africa Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million); Table 32 Middle East And Africa Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 33 Middle East And Africa Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million); Table 34 Middle East And Africa Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million); Table 35 Middle East And Africa Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million); Table 36 Saudi Arabia Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million); Table 37 Saudi Arabia Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 38 Saudi Arabia Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 39 Saudi Arabia Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 40 Saudi Arabia Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million); Table 41 Saudi Arabia Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million); Table 42 Saudi Arabia Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 43 Saudi Arabia Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million); Table 44 Saudi Arabia Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million); Table 45 Saudi Arabia Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million); Table 46 Egypt Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million); Table 47 Egypt Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 48 Egypt Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 49 Egypt Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 50 Egypt Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million); Table 51 Egypt Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million); Table 52 Egypt Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 53 Egypt Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million); Table 54 Egypt Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million); Table 55 Egypt Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million); Table 56 U.A.E. Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million); Table 57 U.A.E. Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 58 U.A.E. Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 59 U.A.E. Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 60 U.A.E. Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million); Table 61 U.A.E. Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million); Table 62 U.A.E. Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 63 U.A.E. Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million); Table 64 U.A.E. Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million); Table 65 U.A.E. Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million); Table 66 South Africa Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million); Table 67 South Africa Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 68 South Africa Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 69 South Africa Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 70 South Africa Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million); Table 71 South Africa Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million); Table 72 South Africa Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 73 South Africa Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million); Table 74 South Africa Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million); Table 75 South Africa Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million); Table 76 Israel Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million); Table 77 Israel Treatment In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 78 Israel Steroid-sparing Immunosuppressant Drugs In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 79 Israel Anti-inflammatory Agents In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 80 Israel Treatment In Pemphigus Vulgaris Market, By Route Of Administration, 2021-2030 (Usd Million); Table 81 Israel Treatment In Pemphigus Vulgaris Market, By Drug Type, 2021-2030 (Usd Million); Table 82 Israel Diagnosis In Pemphigus Vulgaris Market, By Type, 2021-2030 (Usd Million); Table 83 Israel Pemphigus Vulgaris Market, By Population Type, 2021-2030 (Usd Million); Table 84 Israel Pemphigus Vulgaris Market, By End User, 2021-2030 (Usd Million); Table 85 Israel Pemphigus Vulgaris Market, By Distribution Channel, 2021-2030 (Usd Million); Table 86 Rest Of Middle East And Africa Pemphigus Vulgaris Market, By Diagnosis And Treatment, 2021-2030 (Usd Million)
List Of Figures: Figure 1 Middle East & Africa Pemphigus Vulgaris Market: Segmentation; Figure 2 Middle East & Africa Pemphigus Vulgaris Market: Data Triangulation; Figure 3 Middle East & Africa Pemphigus Vulgaris Market: Droc Analysis; Figure 4 Middle East & Africa Pemphigus Vulgaris Market: Middle East & Africa Vs Regional Market Analysis; Figure 5 Middle East & Africa Pemphigus Vulgaris Market: Company Research Analysis; Figure 6 Middle East & Africa Pemphigus Vulgaris Market: Interview Demographics; Figure 7 Middle East & Africa Pemphigus Vulgaris Market: Market Application Coverage Grid; Figure 8 Middle East & Africa Pemphigus Vulgaris Market: Dbmr Market Position Grid; Figure 9 Middle East & Africa Pemphigus Vulgaris Market: Vendor Share Analysis; Figure 10 Middle East & Africa Pemphigus Vulgaris Market: Segmentation; Figure 11 The Emerging Treatment Options For The Pemphigus Vulgarisis Expected To Drive The Growth Of The Middle East & Africa Pemphigus Vulgaris Market From 2023 To 2030; Figure 12 The Diagnosis And Treatment Segment Is Expected To Account For The Largest Share Of The Middle East & Africa Pemphigus Vulgaris Market In 2023 And 2030; Figure 13 Patient Flow Description Of Pemphigus Vulgaris:-; Figure 14 Drivers, Restraints, Opportunities, And Challenges Of Middle East & Africa Pemphigus Vulgaris Market; Figure 15 Middle East & Africa Pemphigus Vulgaris Market: By Diagnosis And Treatment, 2022; Figure 16 Middle East & Africa Pemphigus Vulgaris Market: By Diagnosis And Treatment, 2023-2030 (Usd Million); Figure 17 Middle East & Africa Pemphigus Vulgaris Market: By Diagnosis And Treatment, Cagr (2023-2030); Figure 18 Middle East & Africa Pemphigus Vulgaris Market: By Diagnosis And Treatment, Lifeline Curve; Figure 19 Middle East & Africa Pemphigus Vulgaris Market: By Population Type, 2022; Figure 20 Middle East & Africa Pemphigus Vulgaris Market: By Population Type, 2023-2030 (Usd Million); Figure 21 Middle East & Africa Pemphigus Vulgaris Market: By Population Type, Cagr (2023-2030); Figure 22 Middle East & Africa Pemphigus Vulgaris Market: By Population Type, Lifeline Curve; Figure 23 Middle East & Africa Pemphigus Vulgaris Market: By End User, 2022; Figure 24 Middle East & Africa Pemphigus Vulgaris Market: By End User, 2023-2030 (Usd Million); Figure 25 Middle East & Africa Pemphigus Vulgaris Market: By End User, Cagr (2023-2030); Figure 26 Middle East & Africa Pemphigus Vulgaris Market: By End User, Lifeline Curve; Figure 27 Middle East & Africa Pemphigus Vulgaris Market: By Distribution Channel, 2022; Figure 28 Middle East & Africa Pemphigus Vulgaris Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 29 Middle East & Africa Pemphigus Vulgaris Market: By Distribution Channel, Cagr (2023-2030); Figure 30 Middle East & Africa Pemphigus Vulgaris Market: By Distribution Channel, Lifeline Curve; Figure 31 Middle East And Africa Pemphigus Vulgaris Market: Snapshot (2022); Figure 32 Middle East And Africa Pemphigus Vulgaris Market: By Country (2022); Figure 33 Middle East And Africa Pemphigus Vulgaris Market: By Country (2023 & 2030); Figure 34 Middle East And Africa Pemphigus Vulgaris Market: By Country (2022 & 2030); Figure 35 Middle East And Africa Pemphigus Vulgaris Market: Diagnosis And Treatment (2023-2030); Figure 36 Middle East & Africa Pemphigus Vulgaris Market: Company Share 2022 (%) 117